[PDF][PDF] Comparative study on anti-tumor immune response of autologous cytokine-induced killer (CIK) cells, dendritic cells-CIK (DC-CIK), and semi-allogeneic DC-CIK

QJ Wang, H Wang, K Pan, YQ Li, LX Huang… - … J Cancer, 2010 - researchgate.net
… In addition, we compared the antitumor abilities of autologous CIK cells, DCCIK cells, and
semiallogeneic DCCIK cells to explore the most effective antitumor adoptive immunotherapy

[PDF][PDF] Expression of B7-H1 protein in human pancreatic carcinoma tissues and its clinical significance

XL Chen, SX Yuan, C Chen, YX Mao, G Xu… - Ai Zheng, 2009 - scholar.archive.org
… B7H1 is expressed in lung carcinoma, 1 ovarian carcinoma, … renal carcinoma, 2 breast
carcinoma, 3 and so on. It has … new target for immunotherapy of pancreatic carcinoma in the future…

[PDF][PDF] LAG-3 分子的研究进展

田金, 张腾龙, 李玲, 王洁, 郭成业 - 新医学, 2020 - xinyixue.cn
… LAG-3 is associated with multiple types of tumors,chronic … LAG-3 provides novel targets for
the immunotherapy of various … LAG-3 and its relationship with lung cancer,gastric cancer and …

[HTML][HTML] 帕博利珠单抗在三阴性乳腺癌中的应用

陈波, 宋张骏 - Advances in Clinical Medicine, 2024 - hanspub.org
… of various treatment strategies based on immune checkpoint inhibitors … triple-negative breast
cancer patients, and discussed the prospect of triple-negative breast cancer immunotherapy

早期三阴性乳腺癌新辅助免疫治疗联合化疗的研究进展

韩敬茹, 邓红彬 - 中国肿瘤临床, 2021 - cjco.cn
… 摘要三阴性乳腺癌(triple-negative breast cancer,TNBC)占乳腺… immunotherapy combined
with chemotherapy for early triple-… 三阴性乳腺癌(triple-negative breast cancer,TNBC)是乳腺癌中…

第42 届圣安东尼奥乳腺癌研讨会报道: 三阴性乳腺癌

袁芃 - 中华乳腺病杂志(电子版), 2020 - zhrxbzz.cma-cmc.com.cn
… latest progress in chemotherapy, immunotherapy, new drug development and drug
combinations for triple negative breast cancer. In this article, we reviewed the relevant hot issues. …

[HTML][HTML] 乳腺癌免疫治疗新进展

徐小萌, 韩真真, 袁胜利 - Advances in Clinical Medicine, 2018 - hanspub.org
… 摘要: 近年来肿瘤免疫治疗(cancer immunotherapy, CIT)的发展使… This review looks back at
the theory of the cancer immunity … in breast cancer, especially triple negative breast cancer. …

免疫治疗研究进展及其在三阴性乳腺癌中的应用

郑红梅, 冯尧军, 许娟, 程洪涛, 金立亭, 钟伟, 吴新红 - 肿瘤防治研究, 2020 - zlfzyj.com
… and salvage treatment for metastatic triple negative breast cancer. This paper summarizes
the advances of immunotherapy and its application in triple negative breast cancer with …

PD-1/PD-L1 通路在三阴性乳腺癌预后预测及治疗中的意义.

张凤春, 张硕渊, 陈天恩… - Journal of Shanghai …, 2020 - search.ebscohost.com
… and treatment of cancer. Triple-negative breast cancer (TNBC) is an aggressive subtype
of … Immunotherapy representedPD-1/PD-L1 blockers, is getting widely studied due to the …

溶瘤病毒在乳腺癌治疗中的研究进展

马海燕, 王欣 - 中国肿瘤临床, 2020 - cjco.cn
… At present, many types of OVs are used for breast cancer treatment, with … immunotherapy.
This article reviews the main research progress in oncolytic virus therapy for breast cancers. …